Press Coverage

Taiwan: PharmaEssentia raises US$462.7m from upsized GDS

Excerpt: The issuance is a large one to digest, says Ethan Aw of Aequitas Research in a note published on SmartKarma, as it represents over 17 days of three month average daily volumes. Nevertheless, the…

LaingBuisson • (Opens in a new window) ⧉

Are you a Professional Journalist?

The Smartkarma Press Pass is a special login created exclusively for pre-approved professional journalists. It allows a journalist to access content on the platform and use all the powerful search and discovery functionality available. Journalists can excerpt and quote from the content on Smartkarma to enrich and support their articles.


Request your Press Pass Now